New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 3, 2014
09:14 EDTCACI, FIO, LQDT, BKS, CYTR, MON, PLUG, ORCL, VVUS, LMCAOn The Fly: Pre-market Movers
HIGHER: Plug Power (PLUG), up 3% after agreeing to acquire hydrogen fuel cell stack technology developer ReliOn... Fusion-io (FIO), up 2% after announcing a collaboration with Oracle (ORCL) on the development of flash-aware interfaces for MySQL... Monsanto (MON), up 1.5% following upgrades to Overweight at JPMorgan... CytRx (CYTR), up 9.7% after announcing data from a trial that it said supports the current evaluation of aldoxorubicin as a treatment for patients with GBM tumors. LOWER: Liquidity Services (LQDT), down 13% after confirming it withdrew from live auction bidding for the DoD rolling stock contract, shares downgraded to Neutral at RW Baird... Barnes & Noble (BKS), down 9% after Liberty Media (LMCA) agreed to reduce its stake in B&N... VIVUS (VVUS), down 5% following downgrade to Underweight at Piper Jaffray... CACI International (CACI), down 8.7% after cutting its fiscal 2014 earnings and sales outlook, citing reduced government spending and delays in award activity.
News For BKS;LMCA;PLUG;LQDT;VVUS;MON;FIO;ORCL;CYTR;CACI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 23, 2015
13:39 EDTMONMonsanto addresses assessment on glyphosate by IARC
Monsanto Company further addressed last week’s assessment on glyphosate by the International Agency for Research on Cancer. “We are outraged with this assessment,” said Dr. Robb Fraley, Monsanto’s Chief Technology Officer. “This conclusion is inconsistent with the decades of ongoing comprehensive safety reviews by the leading regulatory authorities around the world that have concluded that all labeled uses of glyphosate are safe for human health. This result was reached by selective ‘cherry picking’ of data and is a clear example of agenda-driven bias.” The repeated safety assessments by regulatory authorities over the last three decades have formed the foundation for the long history of safe, highly effective use of this important agricultural tool in more than 160 countries around the world. Decisions regarding product safety and approvals for pesticides are governed by regulatory agencies such as the U.S. Environmental Protection Agency and the European Commission, as well as independent scientific advisory bodies such as the European Food Safety Authority. IARC has no regulatory authority and its decision does not impact glyphosate’s label, current registration or use. “Safety is the top priority for every person who works at Monsanto. Glyphosate-based herbicides on the market meet the rigorous standards set by the regulatory and health authorities who work every day to protect human health, and we want our customers and consumers to be assured of these evaluations,” Fraley added. In contrast to the comprehensive review that regulators around the world have completed over three decades, IARC issued its classification based on a limited data review after hours of discussion at a one-week meeting. Further, IARC is one of four programs within the WHO that have reviewed the safety of glyphosate and their classification is inconsistent with the assessments of the other programs. Two of the WHO programs – the Core Assessment Group and the International Programme on Chemical Safety – both concluded glyphosate is not carcinogenic. The WHO Guidelines for Drinking-Water Quality program concluded glyphosate does not represent a hazard to human health.
12:17 EDTMONOn The Fly: Midday Wrap
Subscribe for More Information
11:22 EDTORCLOptions with decreasing implied volatility
Options with decreasing implied volatility: FOLD NKTR RUSL XONE GES CTRP WSM NLY ADBE ORCL
11:21 EDTMONOrigin Agritech shares spike higher after report of possible takeover interest
Subscribe for More Information
11:07 EDTMONMonsanto weakness on Glyphosate WHO claims overblown, says Piper Jaffray
Subscribe for More Information
09:46 EDTMONScotts Miracle-Gro slips after report on Monsanto herbicide
Subscribe for More Information
March 22, 2015
16:22 EDTMONChina looks to develop seed program to fend off foreign competition, WSJ says
Subscribe for More Information
14:27 EDTMONWHO says herbicide marketed by Monsanto likely carcinogenic, WSJ says
A World Health Organization agency said Friday that Glyphosate, a herbicide marketed by Monsanto under the Roundup brand and other companies, has the potential to cause cancer in humans, says the Wall Street Journal. Monsanto contested the findings saying that glyphosate is safe if used as recommended by its label and that decades of extensive study have proven its safety, added the Wall Street Journal. Reference Link
March 20, 2015
16:33 EDTORCLStocks end week higher after market reads Fed statement as dovish
Subscribe for More Information
10:18 EDTORCLOptions with decreasing implied volatility
Options with decreasing implied volatility: NKTR FOLD RUSL RSX ORCL GES CTRP SLXP WSM SPXS
March 19, 2015
10:42 EDTORCLOptions with decreasing implied volatility
Subscribe for More Information
March 18, 2015
16:26 EDTORCLOn The Fly: Closing Wrap
Subscribe for More Information
14:37 EDTMONMonsanto and midwest, southeast wheat farmers reach settlement agreement
Subscribe for More Information
12:38 EDTORCLOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday ahead of the conclusion of the Federal Reserve's latest rate setting meeting and the central bank's accompanying announcements. The averages began the session in negative territory and have been range-bound throughout the morning. The Dow was down triple digits once again, making 8 consecutive days that the blue chip index has seen a triple digit move. ECONOMIC EVENTS: In the U.S., the DOE petroleum inventory reports showed a 9.6M barrel rise in crude stocks in the week of March 13, versus expectations for a 4.4M build. The day's big economic news is yet to come, with the Fed's FOMC meeting announcement due at 2:00 pm EDT and Fed Chair Yellen holding a press conference a half hour later. Elsewhere, Prime Minister Benjamin Netanyahu unexpectedly defeated his main challenger in Israel’s election and his Likud party appears set to capture more parliament seats. COMPANY NEWS: Shares of FedEx (FDX) slid 2.5% after the shipping giant reported earnings that beat estimates, but revenue that fell short of the consensus forecast, for its third fiscal quarter. FedEx noted that it expects to deliver "record" yearly earnings for the current fiscal year and next fiscal year as well... Oracle (ORCL) shares rose 2.5% after the company's third quarter profits matched expectations and it raised its quarterly dividend 25%. MAJOR MOVERS: Among the notable gainers was Vitesse Semiconductor (VTSS), which jumped 37% after the company agreed to be acquired for $5.28 per share in cash by Microsemi (MSCC). Also higher was Retrophin (RTRX), which rose 28% after the company said it will exercise its right to purchase from Asklepion Pharmaceuticals all worldwide rights, titles, and ownership of Cholbam after the FDA approved the drug for the treatment of pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for patients with peroxisomal disorders. Among the noteworthy losers was Willbros Group (WG), which dropped 55% and was downgraded to Underperform at DA Davidson after announcing its earnings report will be delayed and the company is in potential non-compliance with debt covenants. Also lower following their earnings reports were Nektar Therapeutics (NKTR), which fell 15% after the company's Phase III BEACON metastatic breast cancer study missed its primary endpoint. INDEXES: Near midday, the Dow was down 105.02, or 0.59%, to 17,744.06, the Nasdaq was down 12.45, or 0.25%, to 4,924.99, and the S&P 500 was down 7.69, or 0.37%, to 2,066.59.
10:02 EDTORCLOracle moves higher post-earnings, levels to watch
Shares are up 4.4% to $44.76 at time of writing, just off the high of the day at $44.94. At that price next resistance is at the 52-week high at $46.71. Support is at $44.30, the opening price of the day.
09:23 EDTORCLOn The Fly: Pre-market Movers
Subscribe for More Information
07:42 EDTORCLOracle remains a favorite large-cap value stock, says Canaccord
Subscribe for More Information
07:25 EDTORCLOracle sentiment should improve following Q3 results, says UBS
UBS noted Oracle reported solid Q3 results, including growth in cloud, infrastructure, and hardware. The results came despite foreign exchange headwinds and the firm now sees investor sentiment improving, resulting in a higher share price. UBS reiterated its Buy rating and raised its price target to $48 from $47 on Oracle shares.
07:01 EDTORCLOracle reported solid results, executing well, says Cantor
Subscribe for More Information
06:04 EDTORCLOracle implied volatility of 30 at upper end of index
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use